These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3559100)

  • 1. Prolonged cholestasis after cyproheptadine-induced acute hepatitis.
    Larrey D; Geneve J; Pessayre D; Machayekhi JP; Degott C; Benhamou JP
    J Clin Gastroenterol; 1987 Feb; 9(1):102-4. PubMed ID: 3559100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis caused by cyproheptadine (Periactine). A case and review of the literature].
    Freneaux E; Larrey D; Berson A; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1988; 12(6-7):573-5. PubMed ID: 3046986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged cholestasis after troleandomycin-induced acute hepatitis.
    Larrey D; Amouyal G; Danan G; Degott C; Pessayre D; Benhamou JP
    J Hepatol; 1987 Jun; 4(3):327-9. PubMed ID: 3496378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline-induced bile duct paucity and prolonged cholestasis.
    Hunt CM; Washington K
    Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestasis in acute alcoholic liver disease.
    Glover SC; McPhie JL; Brunt PW
    Lancet; 1977 Dec 24-31; 2(8052-8053):1305-7. PubMed ID: 74724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-and drug-induced cholestasis.
    Gentilini P; Surrenti C; Chiarantini E
    Acta Gastroenterol Belg; 1979; 42(9-10):369-89. PubMed ID: 554410
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic injury associated with penicillin therapy.
    Goldstein LI; Ishak KG
    Arch Pathol; 1974 Aug; 98(2):114-7. PubMed ID: 4366005
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cholestasis after ajmaline-induced acute hepatitis.
    Larrey D; Pessayre D; Duhamel G; Casier A; Degott C; Feldmann G; Erlinger S; Benhamou JP
    J Hepatol; 1986; 2(1):81-7. PubMed ID: 3950363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute submassive cholestatic hepatitis after treatment with carbimazole. Presentation of a new case and review of the literature].
    Moreno Sánchez D; Medina Asensio J; Colina Ruiz-Delgado F; Campos Cantero R; Crespo Rincón L; Belda Serna A
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):273-6. PubMed ID: 2682839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholestasis.
    Zimmerman HJ
    Arch Intern Med; 1979 Sep; 139(9):1038-45. PubMed ID: 383034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prolonged hepatitis due to ajmaline--description of a case and review of the literature].
    Chammartin F; Levillain P; Silvain C; Chauvin C; Beauchant M
    Schweiz Rundsch Med Prax; 1989 May; 78(20):582-4. PubMed ID: 2568014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methyldopa-induced hepatitis: 3 case reports].
    Daghfous R; el Aidli S; Loueslati MH; Sakka T; Lakhal M; Ben Mami N; Ben Khelifa H; Belkahia CH
    Tunis Med; 1994 Jan; 72(1):47-50. PubMed ID: 8203031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of acute alcoholic hepatitis with histologic changes indicating intrahepatic cholestasis].
    Imoto S; Matsumoto H; Hiraide S; Sakai T; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 1973 Jun; 70(6):587-93. PubMed ID: 4737958
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?
    Etogo-Asse F; Boemer F; Sempoux C; Geubel A
    Acta Gastroenterol Belg; 2008; 71(1):36-8. PubMed ID: 18396749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of cholestasis.
    Popper H; Schaffner F
    Hum Pathol; 1970 Mar; 1(1):1-24. PubMed ID: 4940286
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cholestatic hepatitis associated with piroxicam use. Case report].
    Poniachik J; Guerrero J; Calderón P; Smok G; Morales A; Muñoz G; Venegas M
    Rev Med Chil; 1998 May; 126(5):548-52. PubMed ID: 9731437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
    Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
    Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbimazole-induced acute cholestatic hepatitis.
    Ozenne G; Manchon ND; Doucet J; Hémet J; Schrub JC; Bercoff E
    J Clin Gastroenterol; 1989 Feb; 11(1):95-7. PubMed ID: 2646363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.